Please login to the form below

Not currently logged in
Email:
Password:

S&H wins Doctors' Choice Awards

Sudler & Hennessey has been named a winner of a 2010 Doctors' Choice Awards for its work involving the launch of Simcor

Sudler & Hennessey (S&H) has been named a winner of a 2010 Doctors' Choice Awards. The award recognised S&H's work in the cardiovascular area for the launch of Simcor (simvastati/niacin).

The Doctors' Choice Awards, an annual study developed by Association of Medical Media (AMM), researches physician attitudes toward product advertising. This is done through web-based surveys covering 325 advertisements in 21 specialities, from the 86 most widely-advertised products in the previous calendar year.

The study was conducted by Readex Research, and drew more than 4,600 responses. This is the seventh year AMM has conducted the Doctors' Choice research.

Rob Rogers, co-CEO for S&H in the Americas said: "We are extremely proud of our talented staff and the many effective campaigns developed at S&H each year, a focus on creative that works has led to increased client satisfaction. This award is particularly meaningful as it is judged by the audience that truly matters."

The advertisements were judged on their ability to communicate quickly and clearly; help with clinical decisions; prompt physicians to seek further information or re-examine treatment; add to information generated by company sales representatives; and underscore the value of the product prescribed.

12th October 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics